---
title: "This biotech dealmaker — tied to Merck, Travere — is in a profit-taking zone"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295139243.md"
description: "Ligand stock landed in a profit-taking zone Thursday on a strong second-quarter report and an earnings guidance hike."
datetime: "2026-08-06T20:21:56.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295139243.md)
  - [en](https://longbridge.com/en/news/295139243.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295139243.md)
generator: "portal-rs"
---

# This biotech dealmaker — tied to Merck, Travere — is in a profit-taking zone

Ligand stock landed in a profit-taking zone Thursday on a strong second-quarter report and an earnings guidance hike.

### Related Stocks

- [LGND.US](https://longbridge.com/en/quote/LGND.US.md)
- [TVTX.US](https://longbridge.com/en/quote/TVTX.US.md)
- [MRK.US](https://longbridge.com/en/quote/MRK.US.md)

## Related News & Research

- [JW Asset Management LLC Buys New Shares in Travere Therapeutics, Inc. $TVTX](https://longbridge.com/en/news/298375111.md)
- [Travere Therapeutics director Jeffrey A. Meckler disposes of common shares worth $1.31 million](https://longbridge.com/en/news/298764840.md)
- [Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | TVTX Stock News](https://longbridge.com/en/news/298769998.md)
- [Orchestra BioMed Highlights Pivotal Cardiovascular Program Progress](https://longbridge.com/en/news/298332130.md)
- [Ranger Investment Management L.P. Acquires Shares of 257,596 Ligand Pharmaceuticals Incorporated $LGND](https://longbridge.com/en/news/296772770.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**